Safety and Tolerability of Stribild in the Southeast United States

Conclusion:
Our results demonstrate limited adverse events and low discontinuation rates associated with EVG/COBI/TDF/FTC.

Source: Journal of the International Association of Physicians in AIDS Care (JIAPAC) - August 30, 2016 Category: Infectious Diseases Authors: Derrick, C. B., Lu, Z. K., Caulder, C. R., Hester, E. K., Wagner, T. D., Bookstaver, P. B. Tags: Antiretroviral Therapy Source Type: research